{"protocolSection":{"identificationModule":{"nctId":"NCT06478407","orgStudyIdInfo":{"id":"2024"},"organization":{"fullName":"Tianjin Medical University Eye Hospital","class":"OTHER"},"briefTitle":"Community Screening Study of Diabetic Retinopathy in Tianjin in 2024","officialTitle":"Community Screening Study of Diabetic Retinopathy in Tianjin in 2024","acronym":"CSSODRIT"},"statusModule":{"statusVerifiedDate":"2024-06","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2024-03-28","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2025-03-28","type":"ESTIMATED"},"completionDateStruct":{"date":"2025-03-28","type":"ESTIMATED"},"studyFirstSubmitDate":"2024-06-22","studyFirstSubmitQcDate":"2024-06-22","studyFirstPostDateStruct":{"date":"2024-06-27","type":"ACTUAL"},"lastUpdateSubmitDate":"2024-06-22","lastUpdatePostDateStruct":{"date":"2024-06-27","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR_INVESTIGATOR","investigatorFullName":"Li Xiaorong","investigatorTitle":"PROFESSOR","investigatorAffiliation":"Tianjin Medical University Eye Hospital"},"leadSponsor":{"name":"Li Xiaorong","class":"OTHER"},"collaborators":[{"name":"Tianjin Medical University Eye Hospital","class":"OTHER"}]},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"Through this study, we hope to understand the prevalence and influencing factors of diabetic retinopathy in Tianjin, improve the ability of complication detection and intervention in diabetic patients in primary medical and health institutions, and build a diabetes prevention and treatment network. We should adhere to the policy of prevention first, combined with prevention and control, and explore a diabetes' prevention and control model suitable for our city. Extensive publicity and education should be carried out to improve the awareness of self-management ï¼Œimprove the screening rate of diabetic retinopathy, and reduce the blindness rate.","detailedDescription":"West of the city, and hebei, heping and binhai new area to carry out the work, diabetic retinopathy screening on 18000 diabetic patients in fundus examination. Tianjin medical university eye hospital, project team, formed in grassroots medical institutions are responsible for screening fundus examination in patients with diabetes, related inspection including vision, computer optometry, fundus photography and optical coherence tomography angiography (OCTA), etc. Blood samples were collected from patients in Hexi District and Heping District to detect glycosylated hemoglobin. Glycated albumin, urine ACR and CO breath test were performed in Chu Hsien-I Memorial Hospital of Tianjin Medical University. Health records were established for the screening personnel after the examination"},"conditionsModule":{"conditions":["Diabetic Retinopathy"],"keywords":["diabetic retinopathy"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":true,"targetDuration":"1 Year","designInfo":{"observationalModel":"ECOLOGIC_OR_COMMUNITY","timePerspective":"CROSS_SECTIONAL"},"bioSpec":{"retention":"SAMPLES_WITH_DNA","description":"Blood and Midstream clean urine"},"enrollmentInfo":{"count":18000,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Diabetic retinopathy screening group","description":"Diabetes patients in the community to accept unified eye test, confirm whether patients with diabetic retinopathy"}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Classification of diabetic retinopathy","description":"Fundus images were taken by fundus camera and graded","timeFrame":"At screening"}],"secondaryOutcomes":[{"measure":"blood routine examination","description":"Blood was collected and tested","timeFrame":"At screening"},{"measure":"OCTA imaging indicators","description":"OCTA machine was used to photograph the fundus","timeFrame":"At screening"},{"measure":"blood biochemistry","description":"Blood was collected and tested","timeFrame":"At screening"},{"measure":"glycosylated hemoglobin","description":"Blood was collected and tested","timeFrame":"At screening"},{"measure":"glycated albumin","description":"Blood was collected and tested","timeFrame":"At screening"},{"measure":"Urine ACR","description":"Urine was collected and tested","timeFrame":"At screening"},{"measure":"Blood vessel color Doppler ultrasound of extremities","description":"Blood vessels of extremities were photographed by color Doppler ultrasound","timeFrame":"At screening"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n- 1: Clear awareness, barrier-free communication\n\n2: diabetes\n\nExclusion Criteria:\n\n* 1: Have left the registered home address\n\n  2: In the last 6 months, you have not lived in your place of residence\n\n  3: Have a serious mental illness","healthyVolunteers":true,"sex":"ALL","stdAges":["CHILD","ADULT","OLDER_ADULT"],"studyPopulation":"Patients with diabetes receive a unified eye examination in the community to confirm whether they have diabetic retinopathy","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"centralContacts":[{"name":"Juping Liu, Director","role":"CONTACT","phone":"13752033227","email":"tydljp@126.com"}],"overallOfficials":[{"name":"Xiaorong Li, professor","affiliation":"Tianjin Medical University Eye Hospital","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Tianjin Medical University Eye Hospital","status":"RECRUITING","city":"Tianjin","state":"Tianjin","zip":"300000","country":"China","contacts":[{"name":"Juping Liu","role":"CONTACT","phone":"13752033227","email":"tydljp@126.com"}],"geoPoint":{"lat":39.14222,"lon":117.17667}}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"documentSection":{"largeDocumentModule":{"largeDocs":[{"typeAbbrev":"Prot","hasProtocol":true,"hasSap":false,"hasIcf":false,"label":"Study Protocol","date":"2024-01-26","uploadDate":"2024-06-18T06:01","filename":"Prot_000.pdf","size":208363},{"typeAbbrev":"ICF","hasProtocol":false,"hasSap":false,"hasIcf":true,"label":"Informed Consent Form","date":"2024-01-29","uploadDate":"2024-06-18T06:04","filename":"ICF_001.pdf","size":126151}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-07-01"},"conditionBrowseModule":{"meshes":[{"id":"D000012164","term":"Retinal Diseases"},{"id":"D000003930","term":"Diabetic Retinopathy"}],"ancestors":[{"id":"D000005128","term":"Eye Diseases"},{"id":"D000003925","term":"Diabetic Angiopathies"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000048909","term":"Diabetes Complications"},{"id":"D000003920","term":"Diabetes Mellitus"},{"id":"D000004700","term":"Endocrine System Diseases"}],"browseLeaves":[{"id":"M14999","name":"Retinal Diseases","asFound":"Retinopathy","relevance":"HIGH"},{"id":"M7125","name":"Diabetic Retinopathy","asFound":"Diabetic Retinopathy","relevance":"HIGH"},{"id":"M8271","name":"Eye Diseases","relevance":"LOW"},{"id":"M7120","name":"Diabetic Angiopathies","relevance":"LOW"},{"id":"M17400","name":"Vascular Diseases","relevance":"LOW"},{"id":"M7115","name":"Diabetes Mellitus","relevance":"LOW"},{"id":"M26004","name":"Diabetes Complications","relevance":"LOW"},{"id":"M7862","name":"Endocrine System Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC11","name":"Eye Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"BC19","name":"Gland and Hormone Related Diseases"},{"abbrev":"BC18","name":"Nutritional and Metabolic Diseases"}]}},"hasResults":false}